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Glossary
Absorption-The transport of a chemical from the outer surface of the skin into both the skin and systemic circulation (including penetration, permeation, and resorption).
Acute exposure-Contact with a chemical that occurs once or for only a short period of time.
Cancer-Any one of a group of diseases that occurs when cells in the body become abnormal and grow or multiply out of control.
Contaminant-A chemical that is (1) unintentionally present within a neat substance or mixture at a concentration less than 1.0% or (2) recognized as a potential carcinogen and present within a neat substance or mixture at a concentration less than 0.1%.
Cutaneous (or percutaneous)-Referring to the skin (or through the skin).
Dermal-Referring to the skin.
Dermal contact-Contact with (touching) the skin.
Direct effects-Localized, non-immune-mediated adverse health effects on the skin, including corrosion, primary irritation, changes in skin pigmentation, and reduction/disruption of the skin barrier integrity, occurring at or near the point of contact with chemicals.
Immune-mediated responses-Responses mediated by the immune system, including allergic responses.
Sensitization-A specific immune-mediated response that develops following exposure to a chemical, which, upon re-exposure, can lead to allergic contact dermatitis (ACD) or other immune-mediated diseases such as asthma, depending on the site and route of re-exposure. Substance-A chemical. 
Systemic effects-Systemic

Purpose
This skin notation profile presents (1) a brief summary of epidemiological and toxicological data associated with skin contact with acrylic acid and (2) the rationale behind the hazard-specific skin notation (SK) assignment for acrylic acid. The SK assignment is based on the scientific rationale and logic outlined in the Current Intelligence Bulletin (CIB) 61: A Strategy for Assigning New NIOSH Skin Notations [NIOSH 2009 ]. The summarized information and health hazard assessment are limited to an evaluation of the potential health effects of dermal exposure to acrylic acid. A literature search was conducted through December 2012 to identify information on acrylic acid, including but not limited to data relating to its toxicokinetics, acute toxicity, repeated-dose systemic toxicity, carcinogenicity, biological system/function-specific effects (including reproductive and developmental effects and immunotoxicity), irritation, and sensitization. Information was considered from studies of humans, animals, or appropriate modeling systems that are relevant to assessing the effects of dermal exposure to acrylic acid. 
Overview of SK Assignment
DIR (COR)
. Table 1 provides an overview of the critical effects and data used to develop the SK assignment for acrylic acid. 
Systemic Toxicity from Skin Exposure (SK: SYS)
Limited toxicokinetic data following dermal exposure to acrylic acid were identified. No in vivo data for humans or in vitro data using excised human cadaver skin were identified. Winter and Sipes [1993] applied 100 microliters (µL) of a 4% solution of acrylic acid in acetone to the mid-thoracic region of rats under a charcoal trap mounted on the skin. Seventy-three percent of the applied dose volatilized and was captured in the charcoal traps, 6% of the dose was still detected on the skin, and approximately 17% of the applied dose was detected in urine, feces, CO 2 , and tissue from major organs [Winter and Sipes, 1993] . Black et al. [1995] reported dermal absorption of approximately 11% of acrylic acid in mice and 24% dermal absorption in rats after 40 mg/kg of a solution of acrylic acid and acetone (1:100) was applied to the shaved dorsal skin of the mice and rats. Basic Acrylic Monomer Manufacturers [1993] reported 18% of a 10 mg/kg and 25% of a 40 mg/kg 14C-labelled acrylic acid dose was absorbed through the skin of rats, and 11% of a 10 mg/kg and 11% of a 40 mg/kg 14C-labelled acrylic acid dose were absorbed in mice. The potential of acrylic acid to pose a skin absorption hazard was also evaluated, with use of a predictive algorithm for estimating and evaluating the health hazards of dermal exposure to substances [NIOSH 2009 ]. The evaluation method compares an estimated dose accumulated in the body from skin absorption and an estimated dose from respiratory absorption associated with a reference occupational exposure limit. On the basis of this algorithm, a ratio of the skin dose to the inhalation dose (SI ratio) of 150 was calculated for acrylic acid. An SI ratio of ≥0.1 indicates that skin absorption may significantly contribute to the overall body burden of a substance [NIOSH 2009 ]; therefore, acrylic acid is considered to be absorbed through the skin following dermal exposure. Additional information on the SI ratio and the variables used in its calculation are included in the appendix. Based on the results of in vivo and in vitro dermal absorption studies as well as and the predictions of the mathematical algorithms, acrylic acid can be absorbed through the skin and be systemically available following dermal exposure.
While no estimated dermal lethal dose (LD Lo ) for humans was identified, the reported dermal LD 50 (lethal dose in 50% of exposed animals) values for rabbits were 0.28 milliliter per kilogram body weight (mL/kg) and 0.95 mL/kg (corresponding to 294 mg/kg and 998 mg/kg, respectively) [Smyth et al. 1962; Carpenter et al. 1974] . potential for acute dermal toxicity [NIOSH 2009 ], acrylic acid is considered acutely toxic following dermal exposure.
A limited number of repeat-dose studies following dermal exposure were identified in animals. One such study was a 13-week subchronic dermal toxicity study in which three strains of mice were topically exposed to 0.1 mL acrylic acid in acetone 3 times a week for 13 weeks at concentrations of 0, 1 or 4% (approximately 1 or 4 mg/mouse/application). In this study, McLaughlin et al. [1995] found no effect on body weight, the only systemic effect reported. A lifetime dermal exposure of mice to 1% acrylic acid in acetone volume/volume (v/v) (reported as approximately 0.2 mg/mouse/application) three times per week did not elicit any statistically significant effects on survival [DePass et al. 1984] . No standard toxicity or specialty studies evaluating biological system/function specific effects (including reproductive and developmental effects and immunotoxicity) following dermal exposure to acrylic acid were identified in animals.
No human reports or standard cancer bioassays were identified that evaluated the systemic carcinogenic potential of acrylic acid following dermal exposure. However, the dermal carcinogenic potential of acrylic acid was assessed in mice. In this study, DePass et al. [1984] found no epidermal tumors in any of the 40 mice topically exposed to 1% acrylic acid solution in acetone (v/v) (approximately 0.20 mg/mouse/application) three times per week for a life time. Table 2 summarizes carcinogenic designations of multiple governmental and nongovernmental organizations for acrylic acid. No designation NTP [2014] No designation USEPA [2014] No designation European Parliament [2008] No GHS designation IARC [2007] Group 
Direct Effects on Skin (SK: DIR)
No human or animal in vivo studies on corrosivity or in vitro tests for corrosivity using human skin models or in vitro tests of skin integrity using cadaver skin were identified. ECB [2002] reported 3 cases from an unpublished 1992 study by BASF where 2 of the 3 workers exposed to acrylic acid between 1967 and 1992 reported corrosion to the skin. In animal studies, topical application of an undiluted solution of acrylic acid resulted in necrosis of the skin of rabbits [Smyth et al. 1962; Carpenter et al. 1974] . ECB cited results from 2 unpublished studies by BASF, conducted in 1998 and 1958, that reported necrosis when undiluted acrylic acid was applied to rabbits [ECB 2002 ]. Applications of 5%, but not 1%, acrylic acid solution in acetone for 2 weeks caused skin irritation (peeling and flaking of the skin) in mice [DePass et al. 1984] . Tegeris et al. [1988] and McLaughlin et al. [1995] found no externally visible signs of skin irritation in mice with application of 1% solution of acrylic acid for 13 weeks; however a 4% solution caused significant skin irritation (desquamation, fissures and eschar) and proliferative, degenerative inflammatory changes were detected histologically in the epidermis and dermis from weeks 1 and 2 in these animals. The structure activity relationship model, Deductive Estimation of Risk from Existing Knowledge (DEREK), predicted acrylic acid to be negative for skin irritation.
The available studies indicate that undiluted acrylic acid is an irritant at concentrations up to 5% 
Immune-mediated Responses (SK: SEN)
Very limited data were identified that evaluated the potential for acrylic acid to be a skin sensitizer in humans. Immediate hypersensitivity testing in a chemical worker showed a severe local reaction to 2% acrylic acid, but no reaction to other acrylate compounds, and re-exposure to acrylic acid in the workplace resulted in generalized urticaria [Fowler 1990 ]. Daecke et al. [1993] reported positive response in a patch test in a woman with contact urticaria due to acrylic acid in a polyacrylic monomer in tape adhesive. Conde-Salazar et al. [1988] investigated the sensitization potential in 6 cases presenting with dermatitis to acrylate-based sealants. Patch-tests with 0.1% acrylic acid in petrolatum yielded negative results, indicating no cross-sensitization to acrylic acid; positive responses were, however, observed with other acrylate compounds. In animals, inconsistent results were reported with regard to the sensitization potential of acrylic acid. For example, a few studies utilizing guinea-pig maximization test (GPMT) and Landsteiner Draize test and the Polak test in guinea pigs [Parker and Turk 1983] indicated that acrylic acid is a skin sensitizer. Waegemaekers and van der Walle [1984] observed a positive result in the Freunds Complete Adjuvant test (FCAT) in guinea-pigs; however, the positive response was thought to be due to the impurity, α,β-diacryloxypropionic acid (DAPA) since there was no reaction when the animals were tested with distilled acrylic acid and acrylic acid that did not contain the contaminant DAPA. Waegemaekers and van der Walle [1984] concluded that allergic response to acrylic acid was due to the contaminant DAPA. DAPA is not a contaminant in acrylic acid produced using the current distillation processes [IPCS 1997] . DEREK predicted acrylic acid to be negative as a skin sensitizer.
The available data suggest that the strong sensitization from commercial acrylic acid is due to the presence of impurities (e.g., DAPA) [Waegemaekers and van der Walle 1984] or polymerization inhibitors of acrylic acid (i.e., methoxyphenol, phenothiazine, and diphenyl-p-phenylenediame [IPCS 1997] . In contrast, distilled acrylic acid was not demonstrated to cause skin sensitization, so the SK: SEN is not assigned to acrylic acid.
Summary
Although no studies were identified that fully evaluated potential systemic effects following repeated or prolonged dermal exposure, sufficient data were identified from dermal absorption and penetration studies in animals Results from skin sensitization studies suggest that distilled acrylic acid is not likely to be a skin sensitizer, whereas commercial preparations using methods that do not include distillation are likely to contain impurities or polymerization inhibitors that are potential skin sensitizers [Waegemaekers and van der Walle 1984; IPCS 1997] . Therefore, on the basis of these assessments, acrylic acid is assigned a composite skin notation of SK: SYS-DIR (COR). 
Appendix: Calculation of the SI Ratio for Acrylic Acid
This appendix presents an overview of the SI ratio and a summary of the calculation of the SI ratio for acrylic acid. Although the SI ratio is considered in the determination of a substance's hazard potential following skin contact, it is intended only to serve as supportive data during the assignment of the NIOSH SK. An in-depth discussion on the rationale and calculation of the SI ratio can be found in Appendix B of the Current Intelligence Bulletin (CIB) 61: A Strategy for Assigning New NIOSH Skin Notations [NIOSH 2009 ].
Overview
The SI ratio is a predictive algorithm for estimating and evaluating the health hazards of skin exposure to substances. The algorithm is designed to evaluate the potential for a substance to penetrate the skin and induce systemic toxicity [NIOSH 2009 ]. The goals for incorporating this algorithm into the proposed strategy for assigning SYS notation are as follows:
(1) Provide an alternative method to evaluate substances for which no clinical reports or animal toxicity studies exist or for which empirical data are insufficient to determine systemic effects. (2) Use the algorithm evaluation results to determine whether a substance poses a skin absorption hazard and should be labeled with the SYS notation.
The algorithm evaluation includes three steps:
(1) determining a skin permeation coefficient (k p ) for the substance of interest, (2) estimating substance uptake by the skin and respiratory absorption routes, and (3) evaluating whether the substance poses a skin exposure hazard.
The algorithm is flexible in the data requirement and can operate entirely on the basis of the physicochemical properties of a substance and the relevant exposure parameters. Thus, the algorithm is independent of the need for biologic data. Alternatively, it can function with both the physicochemical properties and the experimentally determined permeation coefficient when such data are available and appropriate for use.
The first step in the evaluation is to determine the k p for the substance to describe the transdermal penetration rate of the substance [NIOSH 2009 ]. The k p , which represents the overall diffusion of the substance through the stratum corneum and into the blood capillaries of the dermis, is estimated from the compound's molecular weight (MW) and base-10 logarithm of its octanol-water partition coefficient (log KOW). In this example, k p is determined for a substance with use of Equation 1. A self-consistent set of units must be used, such as outlined in The second step is to calculate the biologic mass uptake of the substance from skin absorption (skin dose) and inhalation (inhalation dose) during the same period of exposure. The skin dose is calculated as a mathematical product of the kp, the water solubility (SW) of the substance, the exposed skin surface area, and the duration of exposure. Its units are milligrams (mg). Assume that the skin exposure continues for 8 hours to unprotected skin on the palms of both hands (a surface area of 360 squared centimeters [cm 2 ]).
Equation 2: Determination of Skin Dose
Skin dose = k p × S w × Exposed skin surface area × Exposure time = k p (cm/hour) × S w (mg/cm 3 ) × 360 cm 2 × 8 hours
The inhalation dose (in mg) is derived on the basis of the occupational exposure limit (OEL) of the substance-if the OEL is developed to prevent the occurrence of systemic effects rather than sensory/irritant effects or direct effects on the respiratory tract. Assume a continuous exposure of 8 hours, an inhalation volume of 10 cubic meters (m 3 ) inhaled air in 8 hours, and a factor of 75% for retention of the airborne substance in the lungs during respiration (retention factor, or RF). The final step is to compare the calculated skin and inhalation doses and to present the result as a ratio of skin dose to inhalation dose (the SI ratio). This ratio quantitatively indicates (1) the significance of dermal absorption as a route of occupational exposure to the substance and (2) the contribution of dermal uptake to systemic toxicity. If a substance has an SI ratio greater than or equal to 0.1, it is considered a skin absorption hazard. Calculation Table A1 summarizes the data applied in the previously described equations to determine the SI ratio for acrylic acid. The calculated SI ratio was 150. On the basis of these results, acrylic acid is predicted to represent a skin absorption hazard. The OEL used in calculation of the SI ratio for acrylic acid was the NIOSH recommended exposure limit (REL) [NIOSH 2005 ].
